Abstract
Globally, hepatitis B viral infection is a significant health problem leading to one million deaths annually from liver failure, cirrhosis and hepatocellular carcinoma. It has been estimated that 400 million people worldwide are carries of Hepatitis B Virus (HBV), which is an important cause of morbidity and mortality after kidney transplantation.
Citation
Sivakumar SM, Safhi MM, Alam MF, Anwer T, Khan G, Jabeen A. Insight on Hepatitis B Vaccine Adjuvanticity “Future Perspectives”. SM J Hepat Res Treat. 2016; 2(1): 1007. https://dx.doi.org/10.36876/smjhrt.1007